My Cart

Human uPAR coupled magnetic beads (2 µm)

Customer Reviews
Cat. No. / Size
Price
Qty
MBC-K205-2mg
$1070.00
MBC-K205-10mg (5mg X 2)
$3350.00
ETA of in-stock products:2 business days
Sub-Total$ 0

Product Details

  • Items
    Size 2mg
    Size 10mg (5mg × 2)
    Particle size
    2 μm
    2 μm
    Physical appearance
    Powder mixture
    Powder mixture
    Source
    AA Leu 23 - Arg 303 (Accession # Q03405-1)
    AA Leu 23 - Arg 303 (Accession # Q03405-1)
    Amount of Coupled Protein
    >428.44 pmol(15μg) uPAR Protein /mg Beads
    >428.44 pmol(15μg) uPAR Protein /mg Beads
    Formulation
    PBS, pH7.4, with 10% Trehalose
    PBS, pH7.4, with 10% Trehalose
    Reconstitution
    2 mL sterile deionized water (1 mg beads/mL)
    5 mL sterile deionized water (1 mg beads/mL)
  • Product Description

    The Human uPAR-coupled Magnetic Beads is produced by coupling biotinylated human uPAR protein to streptavidin-conjugated magnetic beads. The pre-coupled beads are ready to use for capturing anti-uPAR antibody from your sample with high specificity. The uniform size and large surface-to-volume ratio of the beads ensure highly efficient immunocapture in a simple, fast and convenient workflow with high reproducibility of data.

  • Application

    This product is intended for immunocapture, biopanning. This is a non-sterile product.

    * The Isotype control (Cat. No. SMB-B01) is sold separately.

  • Reconstitution

    See Certificate of Analysis (CoA) for detailed instruction.

  • Storage

    Upon receipt, please store the lyophilized beads at -20°C for long term storage. The shelf life is 2 year at -20°C in lyophilized form.

    Please avoid more than 3 freeze-thaw cycles once reconstitution, immediate use after reconstitution is highly recommended.

  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • Typical Data

     uPAR TYPICAL DATA

    Immobilized 15 μg Human uPAR to 1 mg Beads can bind the Anti-uPAR with an EC50 of 0.6033 μg/mL.

    Protocol

Customer Reviews
Writing Reviews

Recent Advances

 
Drug Development Progress
  • English Name:

    Urokinase plasminogen activator surface receptor

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    7 Details

  • Highest Development Stage:

    Phase 3 Clinical

Contact Us
Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland